Kylie Quinn
After receiving her PhD through the Malaghan Institute of Medical Research in Wellington, New Zealand, Dr Quinn began a post-doctoral fellowship in 2008 in the lab of Dr Robert Seder at the Vaccine Research Center, NIH, USA. While there, she focused on optimising adjuvant and viral vaccine vector selection for induction of T cell immunity, including adjuvants, such as ISCOMs and Poly I:C, and adeno- and pox-viral vectors. This culminated in selection for an Early Career Researcher presentation at the Collaboration for AIDS Vaccine Discovery Annual Meeting 2012 and several publications in 2013. Dr Quinn has recently joined the lab of A. Prof Nicole La Gruta at the Department of Microbiology and Immunology, University of Melbourne, where she continues to focus on development of optimal T cell immunity.
Abstracts this author is presenting: